Congress extends tick-disease research funding through 2030
S. 2398 — Kay Hagan Tick Reauthorization Act · Filed by Susan Collins (R-ME) · 23 cosponsors · Introduced Jul 23, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes two federal programs that fund research and public-health efforts on tick-borne diseases through 2030. It extends the National Strategy and Regional Centers of Excellence in Vector-Borne Diseases, and Enhanced Support to Health Departments programs, both of which were set to expire after 2025. The bill also makes technical corrections to how the Tick-Borne Disease Working Group is referenced in statute.
Why we flagged it
The bill's sole operative function is to extend the sunset dates of two existing federal public-health programs focused on vector-borne disease research and response. It is a routine reauthorization with technical corrections.
What the text implies
- Reauthorization through 2030 commits federal funding for five additional years; any future defunding or program restructuring would require affirmative legislative action rather than occurring by default expiration.
- Technical amendment changing 'in coordination with' to 'acting through' may subtly shift governance structure of the Tick-Borne Disease Working Group, though the practical effect depends on how existing statute defines those terms.
Who stands to gain
public health departments; academic medical centers and research institutions; CDC and NIH (federal agencies receiving appropriations)